-
Do you want to know how reliable your data are?
PAASP is a global leader in the assessment and accreditation of nonclinical research practice in the field of life sciences. We provide services to facilitate the generation of robust and reliable data and enable improved and accelerated decision-making. Our mission is to increase the probability that basic nonclinical discoveries will translate into safe and effective clinical treatments.
PAASPort®
A tool to judge risk of bias in biomedical research
Identify potential sources of bias early and improve decision-making.
START YOUR JOURNEY TO ACCREDITATION
by getting detailed information about PAASPort®
Risks in early-stage biotech investment
As the recent cases illustrate, apparent or actual issues with data integrity and research rigor can damage not only reputation of individual scientists but also affect the value of companies, whether privately held or publicly traded.
PAASP introduces a new service for the investment community engaged in early-stage biotech:
PAASPort®-based assessment of investment opportunities for data integrity and research rigor risks.
PAASP NETWORK PARTNERS ARE SUPPORTED BY
Funder of EQIPD from the Innovative Medicines Initiative 2 Joint Undertaking.
Conferrer of the NIDA Challenge Award and SBIR Grant for PAASPort®.
United States sponsor of the Global Preclinical Data Forum and sponsor of the Negative Data Prize and PEERS project.
PARTNER ORGANIZATIONS
A taste of our most recent headlines.
EQIPD / PAASP Newsletter December 2024
December 23, 2024Dear Colleagues and Friends, Welcome to the PAASP / EQIPD newsletter issue no. 49! This issue includes: We wish all our…
Read MoreCommentary: What if …
December 23, 2024Several years ago we discussed potential scenarios related to the outcome of Cassava’s Phase 3 program. To remind our readers, concerns…
Read MoreUpdate: EU-Funded Project at GoEQIPD is Progressing
December 23, 2024The Guarantors of EQIPD are involved in the EU-funded iRISE project (Improving Reproducibility in Science) and are conducting two studies on the EQIPD…
Read More